Latest dialysis Stories
Second Phase 3 Registrational Study Meets Primary and All Secondary Endpoints THOUSAND OAKS, Calif., Aug.
The Firm is representing numerous individuals who allegedly suffered life-threatening cardiovascular injuries prior to the 2012 NaturaLyte and GranuFlo recall. New
RIVER EDGE, N.J., Aug. 14, 2014 /PRNewswire/ -- Nephros, Inc.
If Implemented, Program Risks Confusing, Misleading Patients and Public WASHINGTON, Aug.
LAWRENCE, Mass., Aug. 12, 2014 /PRNewswire/ -- NxStage Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today that Allan J.
Four internationally renowned renal care specialists to assist Quanta as it prepares for the clinical introduction of its advanced haemodialysis system ALCESTER, England, August 12, 2014 /PRNewswire/
ALCESTER, England, August 7, 2014 /PRNewswire/ -- Quanta Fluid Solutions Ltd ("Quanta" or the "Company"), a pioneering developer of advanced haemodialysis systems, today
DENVER, July 31, 2014 /PRNewswire/ -- DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2014.
Complaint Accuses Fresenius Medical Care of Fraud, May Have Impact on Other Cases DALLAS, TX (PRWEB) July 30, 2014 A formal complaint has been filed
Louisiana’s NaturaLyte and GranuFlo Lawsuit Alleges Fresenius Medical Care Deceived the State into Believing the Recalled Dialysis Products Were Safe and Submitted Requests for Medicaid Reimbursements